Conrad, David,Batenchuk, Cory,Leboeuf, Fabrice,Bell, John Cameron
申请号：
NZ70943913
公开号：
NZ709439A
申请日:
2013.12.20
申请国别(地区):
NZ
年份:
2020
代理人:
摘要：
The invention relates to the use of a non-replicating, Rhabdovirus-derived particle for the manufacture of a medicament for the treatment of leukemia, wherein the particle is able to bind to the surface of a cell and be internalized, and wherein said Rhabdovirus-derived particle comprises an RNA polynucleotide, the RNA structure of which is cross-linked or cleaved to form discontinuous segments of RNA.
